Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)
Titel:
Impact of afatinib dose modification on safety and effectiveness in patients with EGFR mutation-positive advanced NSCLC: Results from a global real-world study (RealGiDo)
Auteur:
Halmos, Balazs Tan, Eng-Huat Soo, Ross A. Cadranel, Jacques Lee, Min Ki Foucher, Pascal Hsia, Te-Chun Hochmair, Maximilian Griesinger, Frank Hida, Toyoaki Kim, Edward Melosky, Barbara Märten, Angela Carcereny, Enric